glp-1 news today cardiovascular outcomes 2025 november The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome GLP-1 Receptor Agonists in Heart
Description
Baral KC et al
Since GLP-1 RAs suppress the appetite, they can lead to nutritional challenges related to protein intake and may cause nutrient deficiencies
Eating less finally feels sustainable instead of a daily battle of willpower, because your biology is finally on your side
How your body responds to the medication and its side effects will guide your provider in selecting the best option for your weight management plan
Propensity score matching was performed on 83 characteristics (see supporting information)
